More on ALNY
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $320.51 |
|
|||
| Open | $317.73 | ||||
| 52 Wk High | $109.10 | ||||
| 52 Wk Low | $31.38 | ||||
| Day High | $321.17 | ||||
| Day Low | $312.09 | ||||
| P/E | N/A | ||||
| EPS | $-1.45 | ||||
| Volume | 996,495 | ||||
- Form 4 ALNYLAM PHARMACEUTICALS, For: Mar 04 Filed by: Garg Pushkal
- Form 4 ALNYLAM PHARMACEUTICALS, For: Mar 04 Filed by: Greenstreet Yvonne
- Form 4 ALNYLAM PHARMACEUTICALS, For: Mar 04 Filed by: Poulton Jeffrey V.
- Form 4 ALNYLAM PHARMACEUTICALS, For: Mar 04 Filed by: Tanguler Tolga
- Form 4 ALNYLAM PHARMACEUTICALS, For: Mar 04 Filed by: Fitzgerald Kevin Joseph
- Form 144 ALNYLAM PHARMACEUTICALS, Filed by: Fitzgerald Kevin Joseph
- Form 144 ALNYLAM PHARMACEUTICALS, Filed by: Garg Pushkal
- Tenaya Therapeutics partners with Alnylam for heart disease targets
- Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
- Form 4 ALNYLAM PHARMACEUTICALS, For: Mar 02 Filed by: Poulton Jeffrey V.
Entities mentioned with ALNY
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Genzyme/Sanofi-Aventis | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
